发明名称 Angiogenesis inhibitors
摘要 An object of the present invention is to find new pharmacological actions of urea compounds having structure represented by the general formula [1]. The urea compounds having the structure represented by the general formula [1] have excellent angiogenesis inhibitory actions. [wherein "A" is -(NR<SUP>4</SUP>)-, -(CR<SUP>5</SUP>R<SUP>6</SUP>)- or -O-, "B" is alkylene or alkenylene, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>are hydrogen, alkyl, alkenyl, adamantylalkyl or the like, R<SUP>3 </SUP>is aryl or an unsaturated heterocycle, and X is oxygen or sulfur.]
申请公布号 US2008161270(A1) 申请公布日期 2008.07.03
申请号 US20080011299 申请日期 2008.01.25
申请人 SANTEN PHARMACEUTICAL CO., LTD. 发明人 MATSUOKA HIDEHITO;NISHIMURA KAZUO;SEIKE HISAYUKI;AONO HIROYUKI;MURAI MASAAKI
分类号 A61K31/44;A61K31/13;A61K31/4409;A61K31/4545;A61K31/47;A61K31/5377;A61K31/695;A61P9/00;A61P9/10;A61P27/02;A61P27/06;A61P35/00;A61P43/00;C07D213/32;C07D213/40;C07D213/56;C07D233/61 主分类号 A61K31/44
代理机构 代理人
主权项
地址